Several BC treatments, including AIs, chemotherapy-induced ovarian failure (CIOF), and antagonists or agonists of the GnRH, cause bone loss in certain women that are significant enough to lead to osteoporosis and fractures [139]. Here, GNRH1 is linked to osteoporosis.